Fuller & Thaler Asset Management
ICPT

Fuller & Thaler Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Fuller & Thaler Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
2023
Q3 		$3.6M Sell
2023
Q2 		$2.23M Buy
2022
Q3 		– Sell
2022
Q2 		$2.28M Buy
2022
Q1 		$2.67M Buy
2021
Q4 		$2.66M Buy
2015
Q1 		– Sell
2014
Q4 		$31K Sell
2014
Q3 		$237K Buy